Pembrolizumab-related renal toxicities: diagnosis first, treatment later-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab-related renal toxicities: diagnosis first, treatment later

Published:2018-12-01 Issue:1 Volume:12 Page:78-80
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Sprangers Ben¹²³

Affiliation:

1. Department of Microbiology and Immunology, Laboratory of Experimental Transplantation, KU Leuven, Leuven, Belgium

2. Department of Nephrology, University Hospitals Leuven, Leuven, Belgium

3. Cancer-Kidney International Network (C-KIN), Leuven, Belgium

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/12/1/78/27721504/sfy114.pdf

Reference10 articles.

1. Immune checkpoint blockade in cancer therapy;Postow;J Clin Oncol,2015

2. The future of immune checkpoint therapy;Sharma;Science,2015

3. Immune-related adverse events associated with immune checkpoint blockade;Postow;N Engl J Med,2018

4. Adverse renal effects of immune checkpoint inhibitors: a narrative review;Wanchoo;Am J Nephrol,2017

5. Management of checkpoint inhibitor-associated renal toxicities;Vanoverbeke;Expert Rev Qual Life Cancer Care,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Trends and Future Directions of Malignancy After kidney Transplantation: A 1970-2022 Bibliometric Analysis;Annals of Transplantation;2023-12-07

2. Drawbacks of immune checkpoint inhibition and rigorous management for immune-related adverse events along with a mathematical model to assess therapy success and optimum therapy duration and a strategy against tumor plasticity;Journal of Cancer Research and Clinical Oncology;2023-04-19

3. Toxicities of Pembrolizumab in Cancer Patients;Highlights in Science, Engineering and Technology;2022-07-27

4. Immunotherapy-related renal toxicity causes reversible renal enlargement;Abdominal Radiology;2022-07-01

5. Imaging Findings in Immunotherapy-related Renal Toxicity;Journal of Immunotherapy;2021-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3